Do We Need to Put Society First? The Potential for Tragedy in Antimicrobial Resistance
Open Access
- 10 January 2006
- journal article
- policy forum
- Published by Public Library of Science (PLoS) in PLoS Medicine
- Vol. 3 (2), e29
- https://doi.org/10.1371/journal.pmed.0030029
Abstract
Antimicrobial use presents a dilemma, say Foster and Grundmann. Appropriate use can benefit individual patients but carries a cost to society by selecting for resistant strains that are difficult to treat.Keywords
This publication has 41 references indexed in Scilit:
- A Breakthrough in R&D for Neglected Diseases: New Ways to Get the Drugs We NeedPLoS Medicine, 2005
- Agricultural Antibiotics and Human HealthPLoS Medicine, 2005
- Antimicrobial Resistance Determinants and Future ControlEmerging Infectious Diseases, 2005
- Coping with the Tragedy of the Commons: Game Structure and Design of RulesJournal of Economic Surveys, 2005
- How Broad Should the Scope of Antibiotics Patents Be?American Journal of Agricultural Economics, 2002
- Costs Associated with a Strict Policy to Eradicate Methicillin-Resistant Staphylococcus aureus in a Dutch University Medical Center: A 10-Year SurveyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- Reputation helps solve the ‘tragedy of the commons’Nature, 2002
- Key issues in developing antibiotic policies: from an institutional level to Europe-wide. European Study Group on Antibiotic Policy (ESGAP), Subgroup IIIClinical Microbiology & Infection, 2001
- Should physicians be gatekeepers of medical resources?Journal of Medical Ethics, 2001
- Can Patents Deter Innovation? The Anticommons in Biomedical ResearchScience, 1998